Found 171 matching trials
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921) PHASE3 The purpose of this study is to assess the efficacy and safety of the combi...
Show More Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Learn More & Join Trial
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer PHASE2 A Lead-in Phase II Multicentre, Randomised, Double-Blind Study Comparing AZ...
Show More Learn More & Join Trial
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy PHASE1 This multicenter, international, Phase Ib/II trial consists of three stages...
Show More Location
HonorHealth Research Institute ? Bisgrove
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) PHASE3 This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Show More Location
Multiple Locations
Learn More & Join Trial
Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance. PHASE2 Here we are going to find a method by using available multiple drugs includ...
Show More Location
Peking University Third Hospital
Learn More & Join Trial
Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel PHASE2 Objective:
To evaluate the safety and efficacy of topical cyclosporine eye...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer PHASE2 The primary purpose of this research study is to see whether adding bavitux...
Show More Location
Ironwood Cancer and Research Center
Learn More & Join Trial
Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment PHASE2 This phase II randomised, double blind, placebo controlled, multicentre tri...
Show More Location
Hunan Province Tumor Hospital
Learn More & Join Trial
A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients PHASE3 Taxotere has been approved by the FDA and is considered a standard treatmen...
Show More Location
Birmingham Hematology Oncology Associates
Learn More & Join Trial
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC PHASE2 In this research study the investigators are looking to see if the combinat...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial